(NP (NP Inhibition/NN) (PP of/IN (NP-COOD (NP HIV-1/NN replication/NN) and/CC (NP NF-kappa/NN B/NN activity/NN))) (PP by/IN (NP-COOD (NP cysteine/NN) and/CC (NP cysteine/NN derivatives/NNS))) ./.)
(S (NP-SBJ HIV-1/NN proviral/JJ DNA/NN) (VP contains/VBZ (NP (NP two/CD binding/VBG sites/NNS) (PP for/IN (NP the/DT transcription/NN factor/NN NF-kappa/NN B/NN)))) ./.)
(S (NP-SBJ HIV-1-infected/JJ individuals/NNS) (VP have/VBP ,/, (PP on/IN (NP average/NN)) ,/, (NP-COOD (NP (NP (ADJP abnormally/RB high/JJ) levels/NNS) (PP of/IN (NP (NP tumour/NN necrosis/NN factor/NN alpha/NN) (PRN -LRB-/-LRB- (NP TNF/NN alpha/NN) -RRB-/-RRB-)))) and/CC (NP (ADJP abnormally/RB low/JJ) plasma/NN cysteine/NN levels/NNS))) ./.)
(S (NP-SBJ We/PRP) (ADVP therefore/RB) (VP investigated/VBD (NP (NP the/DT effects/NNS) (PP of/IN (NP-COOD (NP cysteine/NN) and/CC (NP related/JJ thiols/NNS))) (PP on/IN (NP-COOD (NP HIV-1/NN replication/NN) and/CC (NP NF-kappa/NN B/NN expression/NN))))) ./.)
(S (NP-SBJ (NP The/DT experiments/NNS) (PP in/IN (NP this/DT report/NN))) (VP show/VBP (SBAR that/IN (S (NP-SBJ-COOD (NP cysteine/NN) or/CC (NP (NP N-acetylcysteine/NN) (PRN -LRB-/-LRB- (NP NP/NN) -RRB-/-RRB-))) (VP (VP-COOD (VP raise/VBP (NP (NP the/DT intracellular/JJ glutathione/NN -LRB-/-LRB- GSH/NN -RRB-/-RRB- level/NN) (PP *RNR*-40/-NONE-))) and/CC (VP inhibit/VBP (NP (NP HIV-1/NN replication/NN) (PP *RNR*-40/-NONE-)))) (PP-40 in/IN (NP (ADJP persistently/RB infected/JJ) (NP-COOD (NP Molt-4/NN) and/CC (NP U937/NN)) cells/NNS)))))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ-102 (NP inhibition/NN) (PP of/IN (NP HIV-1/NN replication/NN))) (VP appears/VBZ (VP not/RB to/TO (VP be/VB (ADVP directly/RB) (VP correlated/VBN (NP *-102/-NONE-) (PP with/IN (NP GSH/NN levels/NNS)))))) ./.)
(S (NP-SBJ (NP Cysteine/NN) and/CC (NP NP/NN)) (ADVP also/RB) (VP inhibit/VBP (NP-COOD (NP (NP NF-kappa/NN B/NN activity/NN) (SBAR as/IN (S (NP-SBJ-41 */-NONE-) (VP determined/VBN (NP *-41/-NONE-) (PP by/IN (NP electrophoretic/JJ mobility/NN shift/NN assays/NNS)))))) and/CC (NP (NP (NP (NP chloramphenicol/NN acetyl-transferase/NN) (PRN -LRB-/-LRB- (NP CAT/NN) -RRB-/-RRB-)) gene/NN expression/NN) (PP under/IN (NP (NP control/NN) (PP of/IN (NP (NP NF-kappa/NN B/NN binding/NN sites/NNS) (PP in/IN (NP uninfected/JJ cells/NNS))))))))) ./.)
(S (NP-SBJ This/DT) (VP suggests/VBZ (SBAR that/IN (S (NP-SBJ (NP the/DT cysteine/NN deficiency/NN) (PP in/IN (NP HIV-1-infected/JJ individuals/NNS))) (VP may/MD (VP-COOD (VP cause/VB (NP (NP an/DT over-expression/NN) (PP of/IN (NP (ADJP NF-kappa/NN B-dependent/JJ) genes/NNS)))) and/CC (VP enhance/VB (NP HIV-1/NN replication/NN))))))) ./.)
(S (NP-SBJ-42 NP/NN) (VP may/MD (VP be/VB (VP considered/VBN (NP *-42/-NONE-) (PP for/IN (NP (NP the/DT treatment/NN) (PP of/IN (NP HIV-1-infected/JJ individuals/NNS))))))) ./.)
